HWCI Radiation Oncology Evaluation - September 25, 2026

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Describe the temporal changes in diffuse fibrosis, dense fibrosis, and tumor oxygenation (hypoxia) during external beam radiation therapy (EBRT) for cervical cancer, based on longitudinal MRI assessment.	Describe the temporal changes in diffuse fibrosis, dense fibrosis, and tumor oxygenation (hypoxia) during external beam radiation therapy (EBRT) for cervical cancer, based on longitudinal MRI assessment. - 5	Describe the temporal changes in diffuse fibrosis, dense fibrosis, and tumor oxygenation (hypoxia) during external beam radiation therapy (EBRT) for cervical cancer, based on longitudinal MRI assessment. - 4	Describe the temporal changes in diffuse fibrosis, dense fibrosis, and tumor oxygenation (hypoxia) during external beam radiation therapy (EBRT) for cervical cancer, based on longitudinal MRI assessment. - 3	Describe the temporal changes in diffuse fibrosis, dense fibrosis, and tumor oxygenation (hypoxia) during external beam radiation therapy (EBRT) for cervical cancer, based on longitudinal MRI assessment. - 2	Describe the temporal changes in diffuse fibrosis, dense fibrosis, and tumor oxygenation (hypoxia) during external beam radiation therapy (EBRT) for cervical cancer, based on longitudinal MRI assessment. - 1
Evaluate the impact of fibrosis and hypoxia dynamics on tumor response to subsequent radiation dose fractions and overall treatment effectiveness.	Evaluate the impact of fibrosis and hypoxia dynamics on tumor response to subsequent radiation dose fractions and overall treatment effectiveness. - 5	Evaluate the impact of fibrosis and hypoxia dynamics on tumor response to subsequent radiation dose fractions and overall treatment effectiveness. - 4	Evaluate the impact of fibrosis and hypoxia dynamics on tumor response to subsequent radiation dose fractions and overall treatment effectiveness. - 3	Evaluate the impact of fibrosis and hypoxia dynamics on tumor response to subsequent radiation dose fractions and overall treatment effectiveness. - 2	Evaluate the impact of fibrosis and hypoxia dynamics on tumor response to subsequent radiation dose fractions and overall treatment effectiveness. - 1
Assess emerging strategies to address severe tumor hypoxia, including brachytherapy-based dose escalation, interventions to improve tumor oxygenation, and approaches designed to mitigate fibrosis-related perfusion deficits in order to optimize treatment outcomes.	Assess emerging strategies to address severe tumor hypoxia, including brachytherapy-based dose escalation, interventions to improve tumor oxygenation, and approaches designed to mitigate fibrosis-related perfusion deficits in order to optimize treatment outcomes. - 5	Assess emerging strategies to address severe tumor hypoxia, including brachytherapy-based dose escalation, interventions to improve tumor oxygenation, and approaches designed to mitigate fibrosis-related perfusion deficits in order to optimize treatment outcomes. - 4	Assess emerging strategies to address severe tumor hypoxia, including brachytherapy-based dose escalation, interventions to improve tumor oxygenation, and approaches designed to mitigate fibrosis-related perfusion deficits in order to optimize treatment outcomes. - 3	Assess emerging strategies to address severe tumor hypoxia, including brachytherapy-based dose escalation, interventions to improve tumor oxygenation, and approaches designed to mitigate fibrosis-related perfusion deficits in order to optimize treatment outcomes. - 2	Assess emerging strategies to address severe tumor hypoxia, including brachytherapy-based dose escalation, interventions to improve tumor oxygenation, and approaches designed to mitigate fibrosis-related perfusion deficits in order to optimize treatment outcomes. - 1

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence NA|Not applicable to my practice

	5	4	3	2	1
Identify dense fibrosis and oxygenation.	Identify dense fibrosis and oxygenation. - 5	Identify dense fibrosis and oxygenation. - 4	Identify dense fibrosis and oxygenation. - 3	Identify dense fibrosis and oxygenation. - 2	Identify dense fibrosis and oxygenation. - 1
Identify brachytherapy, oxygenation or fibrosis-retardation solutions.	Identify brachytherapy, oxygenation or fibrosis-retardation solutions. - 5	Identify brachytherapy, oxygenation or fibrosis-retardation solutions. - 4	Identify brachytherapy, oxygenation or fibrosis-retardation solutions. - 3	Identify brachytherapy, oxygenation or fibrosis-retardation solutions. - 2	Identify brachytherapy, oxygenation or fibrosis-retardation solutions. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so?

Please provide any additional comments or suggestions.

Name and ABS ID Required to claim MOC

You are here

HWCI Radiation Oncology Evaluation - September 25, 2026